MHC Class II Immunodominant Epitope Prediction With Peptidomic Deep Learning
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods struggle to predict and identify immunodominant epitopes for CD4 T cell responses, particularly from complex microorganisms, due to the complexity of antigen processing and limited understanding of antigenicity and immunodominance.
Innovation Solution
A deep neural network is trained using peptidomic data from MHCII complexes in antigen presenting cells to predict MHCII binding peptides and identify immunodominant epitopes from genome sequences, utilizing a deep neural network to generate a ranked set of antigenic epitopes.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If deep neural network is trained using peptidomic data from MHCII complexes to predict MHCII binding peptides, then prediction accuracy of immunodominant epitopes is improved, but computational complexity and data processing requirements increase
Solution Approach 1:
The system performs preliminary action by training the deep neural network model in advance using extensive peptidomic data from MHCII complexes. This pre-training phase captures complex binding patterns and epitope characteristics, allowing the model to make accurate predictions without requiring complex real-time computations during actual epitope identification tasks.
Solution Approach 2:
The invention uses computational modeling to create a virtual representation of MHCII-peptide binding interactions. Instead of performing complex physical experiments to determine epitope binding, the system copies the binding patterns observed in training data and applies them through the neural network model, significantly reducing computational complexity while maintaining prediction accuracy.
2Measurement precision
If unbiased approaches are used to identify autologous self-epitopes through MHCII-associated peptide purification and sequencing, then epitope discovery accuracy is improved, but technical limitations and processing difficulty increase
Solution Approach 1:
The invention replaces complex mechanical and experimental systems (MHCII complex purification, peptide extraction, Edman degradation sequencing, and mass spectrometry) with a computational neural network model. The model processes genome sequences directly to predict epitopes, eliminating the need for labor-intensive wet lab procedures while maintaining or improving discovery accuracy.
Solution Approach 2:
The deep neural network acts as an intermediary between genome sequence data and epitope identification. Instead of directly performing complex purification and sequencing experiments, the model serves as a computational mediator that translates genomic information into predicted immunodominant epitopes, bypassing many technical limitations of traditional methods.
3Ease of manufacture
If traditional empirical methods are used to define immunodominant CD4 T cell epitopes, then simplicity of methodology is maintained, but prediction accuracy and reliability decrease
Solution Approach 1:
The system copies successful patterns from training data consisting of known MHCII-bound peptides and applies these learned patterns to predict epitopes from new genome sequences. This computational copying of binding patterns maintains methodological simplicity while dramatically improving prediction accuracy compared to traditional empirical approaches.
Solution Approach 2:
The invention transforms the approach from empirical observation to data-driven prediction by changing key parameters: using deep neural networks instead of manual analysis, processing genome sequences directly instead of purified peptides, and applying machine learning optimization instead of traditional statistical methods. These parameter changes maintain computational accessibility while improving reliability.
Data Source
AI summary
A system and method for prediction of immunodominant epitopes is provided herein. MHCII peptidomics was used to discover complex bacterial epitopes and host antigen processing pathways. Novel insights into the features of antigenicity are leveraged to build an algorithm for prediction of immunodominant epitopes. Use of immunodominant epitopes is described.